ft 17 sep 93 technolog gain upper hand continu seri drug discoveri clive cookson consid develop treatment diabet pharmaceut industri begin give diabet attent deserv one western world seriou fastest grow chronic diseas diabet complic alreadi kill 160 000 peopl year us prospect immedi futur includ easier way administ insulin tradit self inject new hormon enhanc effect insulin first drug design treat medic complic diabet ahead lie possibl cure prevent diabet interven diseas process molecular level diabet ultim auto immun diseas trigger combin genet environment factor bodi immun system destroy cell pancrea make insulin hormon control blood glucos sugar level isol insulin frederick bant charl best 1921 anyon sever form diseas known type 1 juvenil onset diabet soon fell coma die 1920 1930 two compani still domin intern insulin product today eli lilli us novo nordisk denmark set plant extract hormon pig cow pancreas diabet could stop fall fatal coma regular inject insulin cure diabet becam instead chronic degen diseas multitud life shorten complic includ poor blood flow blind kidney failur sever nerv damag neuropathi worldwid sale diabet drug worth dollar 2 5bn pound 1 6bn 1992 grow 10 per cent year accord lehman brother intern secur compani insulin 60 per cent market remaind oral hypoglycaem drug taken peopl type 2 adult onset diabet less sever form diseas import develop 1980 genet engin bacteria yeast make insulin ident hormon produc human pancrea human insulin advantag unlik anim insulin stimul unwant antibodi patient two third diabet switch anim human insulin put report patient human insulin like suffer acut hypoglycaemia sudden potenti fatal fall blood sugar level gave fewer warn sign impend attack sweat tremor drug therapeut bulletin publish uk consum associ conclud year review clinic data human insulin safe anim version time insulin manufactur make easier diabet inject 1920 patient use ground glass syring sterilis alcohol everi time use minimum standard throw away plastic syring ultra thin needl caus littl pain skin damag diabet use conveni pre fill inject pen altern hi tech deliveri system insulin pump infus insulin slowli steadili patient bloodstream advantag reproduc hormon flow real pancrea accur inject disadvantag includ cost dollar 4 000 inconveni alway devic size cigarett pack strap one bodi year novo nordisk agre promot pump manufactur minim us insulin prepar danish compani estim 25 000 diabet worldwid pump 750 000 use novopen inject system research aim remov need inject pump altogeth develop form insulin could taken mouth nasal spray given gener disappoint result sever group come experiment form oral insulin hormon given coat gelatin biodegrad plastic protect digest juic stomach releas bloodstream intestin wall none far give suffici reliabl dose insulin novo nordisk spent lot time money develop nasal insulin prepar abandon project last year clinic trial show suffici effect reduc glucos level blood benefit control blood sugar tightli possibl shown result nine year studi sponsor us nation institut health releas june type 1 diabet inject three time day use insulin pump reduc risk complic half comparison one two insulin shot per day studi like stimul sale pump inject pen also glucos monitor devic dispos test strip produc compani medisens quit differ approach better control blood sugar base anoth pancreat hormon amylin discov 1987 medic research council group oxford univers appear type 1 diabet short amylin well insulin wherea type 2 diabet make much amylin compani set california exploit oxford discoveri amylin pharmaceut carri clinic trial ac137 synthet version hormon preliminari result announc month suggest ac137 inject insulin help smooth rise fall blood sugar level amylin also work glaxo largest uk pharmaceut compani develop amylin blocker drug type 2 diabet two candid due start clinic trial next year drug avail today type 2 diabet oral hypoglycaem stimul insulin product lead manufactur hoechst germani upjohn pfizer us compani tri tackl diabet fundament level block auto immun reaction destroy patient insulin produc cell drug suppress immun system cyclosporin delay onset diseas side effect rule routin therapi hunt specif treatment one candid fusion toxin produc seragen us diabet alreadi lost capac make insulin best long term prospect may form artifici pancrea two us compani cytotherapeut biohybrid develop technolog transplant insulin produc islet cell diabet cell encapsul semi permeabl polym membran protect destruct patient immun system system work diabet anim begin clinic trial although unlik avail commerci sever year one activ area diabet research treatment diabet complic first drug design protect kidney nerv eye cell toxic product abnorm sugar metabol begin reach market aldos reductas inhibitor one categori pioneer american home product scotia uk carri clinic trial ef4 mixtur fatti acid extract even primros oil appear protect nerv fibr increas blood flow leg feet arm hand david tomlinson professor pharmacolog queen mari colleg london outlin radic approach diabet neuropathi meet british pharmacolog societi month propos repair damag neurotroph factor recent discov compound stimul growth nerv cell seri continu next month articl anaesthet articl seri last six month look pharmaceut advanc follow area epilepsi 27 august arthriti 27 juli menopaus 25 june alzheim 24 may allergi 29 april high blood pressur 18 march